Skip to main content
Top
Published in: Annals of Hematology 10/2004

01-10-2004 | Original Article

Frequency of the C282Y and H63D mutations of the hemochromatosis gene (HFE) in 2501 ethnic Danes

Authors: Nils Milman, Palle Pedersen, Lars Ovesen, Gitte V. Melsen, Kirsten Fenger

Published in: Annals of Hematology | Issue 10/2004

Login to get access

Abstract

The aim of the study was to assess the frequency of the C282Y and H63D mutations of the hemochromatosis gene (HFE) in ethnic Danes. The series comprised 2501 subjects (1284 men) of Danish heritage who were drawn at random from the Census Registry in age cohorts of 30, 40, 50, and 60 years. The frequency of the C282Y and H63D mutations was assessed on blood samples by genotyping using a polymerase chain reaction (PCR) technique. The HFE genotype distribution was in Hardy–Weinberg equilibrium (p=0.85). C282Y mutation: 9 subjects (0.36%) were homozygous and 265 subjects (10.6%) were heterozygous. H63D mutation: 40 subjects (1.6%) were homozygous and 584 subjects (23.4%) were heterozygous. C282Y/H63D compound heterozygosity was found in 36 subjects (1.4%). The C282Y allele frequency was 5.7% [95% confidence interval (CI) 5.0–6.3%] and the H63D allele frequency was 13.3% (95% CI 12.3–14.2%). In conclusion, the C282Y frequency is relatively high in the Danes, being close to the frequency in other Scandinavian countries, i.e., Iceland 5.1%, the Faroe Islands 6.6%, and Sweden 5.7%, but significantly lower than in Norway 6.6% (p=0.02). Also, the H63D frequency in Danes is close to and not significantly different from the frequency in Iceland 10.9%, Norway 11.2%, and Sweden 12.4%, but significantly lower than in the Faroe Islands 15.4% (p=0.046).
Literature
1.
go back to reference Feder JN, Gnirke A, Thomas W, Tsuchihashi Z, Ruddy DA, Basava A et al (1996) A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis. Nat Genet 13:399–408PubMed Feder JN, Gnirke A, Thomas W, Tsuchihashi Z, Ruddy DA, Basava A et al (1996) A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis. Nat Genet 13:399–408PubMed
3.
go back to reference Milman N (2000) Inheritance of hemochromatosis: family studies. In: Barton JC, Edwards CQ (eds) Hemochromatosis: genetics, pathophysiology, diagnosis and treatment. Cambridge University, Cambridge, UK 15–41 Milman N (2000) Inheritance of hemochromatosis: family studies. In: Barton JC, Edwards CQ (eds) Hemochromatosis: genetics, pathophysiology, diagnosis and treatment. Cambridge University, Cambridge, UK 15–41
4.
go back to reference Jørgensen T (1987) Prevalence of gallstones in a Danish population. Am J Epidemiol 126:912–921PubMed Jørgensen T (1987) Prevalence of gallstones in a Danish population. Am J Epidemiol 126:912–921PubMed
5.
go back to reference Rudbeck L, Dissing J (1998) Rapid, simple alkaline extraction of human genomic DNA from whole blood, buccal epithelial cells, semen and forensic stains for PCR. Biotechniques 25:588–590PubMed Rudbeck L, Dissing J (1998) Rapid, simple alkaline extraction of human genomic DNA from whole blood, buccal epithelial cells, semen and forensic stains for PCR. Biotechniques 25:588–590PubMed
6.
go back to reference Milman N, Pedersen P (2003) Evidence that the Cys282Tyr mutation of the HFE gene originated from a population in Southern Scandinavia and spread with the Vikings. Clin Genet 64:36–47CrossRefPubMed Milman N, Pedersen P (2003) Evidence that the Cys282Tyr mutation of the HFE gene originated from a population in Southern Scandinavia and spread with the Vikings. Clin Genet 64:36–47CrossRefPubMed
7.
go back to reference Milman N, Koefoed P, Pedersen P, Nielsen FC, Eiberg H (2003) Frequency of the HFE C282Y and the H63D mutations in Danish patients with clinical haemochromatosis initially diagnosed by phenotypic methods. Eur J Haematol 71:403–407CrossRefPubMed Milman N, Koefoed P, Pedersen P, Nielsen FC, Eiberg H (2003) Frequency of the HFE C282Y and the H63D mutations in Danish patients with clinical haemochromatosis initially diagnosed by phenotypic methods. Eur J Haematol 71:403–407CrossRefPubMed
8.
go back to reference Wiggers P, Dalhøj J, Kiær H, Ring-Larsen H, Petersen PH, Blaabjerg O et al (1991) Screening for haemochromatosis: prevalence among Danish blood donors. J Intern Med 230:265–270PubMed Wiggers P, Dalhøj J, Kiær H, Ring-Larsen H, Petersen PH, Blaabjerg O et al (1991) Screening for haemochromatosis: prevalence among Danish blood donors. J Intern Med 230:265–270PubMed
9.
go back to reference Merryweather-Clarke AT, Simonsen H, Shearman JD, Pointon JJ, Norgaard-Pedersen B, Robson KJ (1999) A retrospective anonymous pilot study in screening newborns for HFE mutations in Scandinavian populations. Hum Mutat 13:154–159CrossRefPubMed Merryweather-Clarke AT, Simonsen H, Shearman JD, Pointon JJ, Norgaard-Pedersen B, Robson KJ (1999) A retrospective anonymous pilot study in screening newborns for HFE mutations in Scandinavian populations. Hum Mutat 13:154–159CrossRefPubMed
10.
go back to reference Steffensen R, Varming K, Jersild C (1998) Determination of gene frequencies for two common haemochromatosis mutations in the Danish population by a novel polymerase chain reaction with sequence-specific primers. Tissue Antigens 52:230–235PubMed Steffensen R, Varming K, Jersild C (1998) Determination of gene frequencies for two common haemochromatosis mutations in the Danish population by a novel polymerase chain reaction with sequence-specific primers. Tissue Antigens 52:230–235PubMed
11.
go back to reference Simonsen K, Dissing J, Rudbeck L, Schwartz M (1999) Rapid and simple determination of hereditary haemochromatosis mutations by multiplex PCR-SSCP: detection of a new polymorphic mutation. Ann Hum Genet 63:193–197 Simonsen K, Dissing J, Rudbeck L, Schwartz M (1999) Rapid and simple determination of hereditary haemochromatosis mutations by multiplex PCR-SSCP: detection of a new polymorphic mutation. Ann Hum Genet 63:193–197
12.
go back to reference Ellervik C, Mandrup-Poulsen T, Nordestgaard BG, Larsen LE, Appleyard M, Frandsen M et al (2001) Prevalence of hereditary haemochromatosis in late-onset type 1 diabetes mellitus: a retrospective study. Lancet 358:1405–1409PubMed Ellervik C, Mandrup-Poulsen T, Nordestgaard BG, Larsen LE, Appleyard M, Frandsen M et al (2001) Prevalence of hereditary haemochromatosis in late-onset type 1 diabetes mellitus: a retrospective study. Lancet 358:1405–1409PubMed
13.
go back to reference Distante S, Berg JP, Lande K, Haug E, Bell H (2000) HFE gene mutation (C282Y) and phenotypic expression among a hospitalised population in a high prevalence area of haemochromatosis. Gut 47:575–579CrossRefPubMed Distante S, Berg JP, Lande K, Haug E, Bell H (2000) HFE gene mutation (C282Y) and phenotypic expression among a hospitalised population in a high prevalence area of haemochromatosis. Gut 47:575–579CrossRefPubMed
14.
go back to reference Undlien DE, Bell H, Heier HE, Akselsen HE, Thorsby E (1998) Genetic diagnostic test for haemochromatosis. Tidsskr Nor Laegeforen 118:238–240PubMed Undlien DE, Bell H, Heier HE, Akselsen HE, Thorsby E (1998) Genetic diagnostic test for haemochromatosis. Tidsskr Nor Laegeforen 118:238–240PubMed
15.
go back to reference Beckman LE, Sjoberg K, Eriksson S, Beckman L (2001) Haemochromatosis gene mutations in Finns, Swedes and Swedish Saamis. Hum Hered 52:110–112CrossRefPubMed Beckman LE, Sjoberg K, Eriksson S, Beckman L (2001) Haemochromatosis gene mutations in Finns, Swedes and Swedish Saamis. Hum Hered 52:110–112CrossRefPubMed
16.
go back to reference Tuomainen TP, Kontula K, Nyyssonen K, Lakka TA, Helio T, Salonen JT (1999) Increased risk of acute myocardial infarction in carriers of the hemochromatosis gene Cys282Tyr mutation: a prospective cohort study in men in eastern Finland. Circulation 100:1274–1279PubMed Tuomainen TP, Kontula K, Nyyssonen K, Lakka TA, Helio T, Salonen JT (1999) Increased risk of acute myocardial infarction in carriers of the hemochromatosis gene Cys282Tyr mutation: a prospective cohort study in men in eastern Finland. Circulation 100:1274–1279PubMed
17.
go back to reference Merryweather-Clarke AT, Pointon JJ, Shearman JD, Robson KJ (1997) Global prevalence of putative haemochromatosis mutations. J Med Genet 34:275–278PubMed Merryweather-Clarke AT, Pointon JJ, Shearman JD, Robson KJ (1997) Global prevalence of putative haemochromatosis mutations. J Med Genet 34:275–278PubMed
18.
go back to reference Cardoso EM, Stal P, Hagen K, Cabeda JM, Esin S, de Sousa M et al (1998) HFE mutations in patients with hereditary haemochromatosis in Sweden. J Intern Med 243:203–208CrossRefPubMed Cardoso EM, Stal P, Hagen K, Cabeda JM, Esin S, de Sousa M et al (1998) HFE mutations in patients with hereditary haemochromatosis in Sweden. J Intern Med 243:203–208CrossRefPubMed
19.
go back to reference Milman N, á Steig T, Koefoed P, Pedersen P, Fenger K, Nielsen FC (2004) Frequency of the haemochromatosis HFE mutations C282Y, H63D and S65C in blood donors in the Faroe Islands. Ann Hematol (in press) Milman N, á Steig T, Koefoed P, Pedersen P, Fenger K, Nielsen FC (2004) Frequency of the haemochromatosis HFE mutations C282Y, H63D and S65C in blood donors in the Faroe Islands. Ann Hematol (in press)
20.
go back to reference Murphy S, Curran MD, McDougall N, Callender ME, O’Brien CJ, Middleton D (1998) High incidence of the Cys282Tyr mutation in the HFE gene in the Irish population—implications for haemochromatosis. Tissue Antigens 52:484–488PubMed Murphy S, Curran MD, McDougall N, Callender ME, O’Brien CJ, Middleton D (1998) High incidence of the Cys282Tyr mutation in the HFE gene in the Irish population—implications for haemochromatosis. Tissue Antigens 52:484–488PubMed
21.
go back to reference Byrnes V, Ryan E, Barrett S, Kenny P, Mayne P, Crowe J (2001) Genetic hemochromatosis, a Celtic disease: is it now time for population screening? Genet Test 5:127–130CrossRefPubMed Byrnes V, Ryan E, Barrett S, Kenny P, Mayne P, Crowe J (2001) Genetic hemochromatosis, a Celtic disease: is it now time for population screening? Genet Test 5:127–130CrossRefPubMed
22.
go back to reference Ryan E, O’Keane C, Crowe J (1998) Hemochromatosis in Ireland and HFE. Blood Cells Mol Dis 24:428–432CrossRefPubMed Ryan E, O’Keane C, Crowe J (1998) Hemochromatosis in Ireland and HFE. Blood Cells Mol Dis 24:428–432CrossRefPubMed
23.
go back to reference Merryweather-Clarke AT, Pointon JJ, Jouanolle AM, Rochette J, Robson KJ (2000) Geography of HFE C282Y and H63D mutations. Genet Test 4:183–198CrossRefPubMed Merryweather-Clarke AT, Pointon JJ, Jouanolle AM, Rochette J, Robson KJ (2000) Geography of HFE C282Y and H63D mutations. Genet Test 4:183–198CrossRefPubMed
24.
go back to reference Jones DC, Young NT, Pigott C, Fuggle SV, Barnardo MC, Marshall SE et al (2002) Comprehensive hereditary hemochromatosis genotyping. Tissue Antigens 60:481–488CrossRefPubMed Jones DC, Young NT, Pigott C, Fuggle SV, Barnardo MC, Marshall SE et al (2002) Comprehensive hereditary hemochromatosis genotyping. Tissue Antigens 60:481–488CrossRefPubMed
25.
go back to reference Mullighan CG, Bunce M, Fanning GC, Marshall SE, Welsh KI (1998) A rapid method of haplotyping HFE mutations and linkage disequilibrium in a Caucasoid population. Gut 42:566–569PubMed Mullighan CG, Bunce M, Fanning GC, Marshall SE, Welsh KI (1998) A rapid method of haplotyping HFE mutations and linkage disequilibrium in a Caucasoid population. Gut 42:566–569PubMed
26.
go back to reference Miedzybrodzka Z, Loughlin S, Baty D, Terron A, Kelly K, Dean J et al (1999) Haemochromatosis mutations in North-East Scotland. Br J Haematol 106:385–387CrossRefPubMed Miedzybrodzka Z, Loughlin S, Baty D, Terron A, Kelly K, Dean J et al (1999) Haemochromatosis mutations in North-East Scotland. Br J Haematol 106:385–387CrossRefPubMed
27.
go back to reference Grove J, Daly AK, Burt AD, Guzail M, James OF, Bassendine MF et al (1998) Heterozygotes for HFE mutations have no increased risk of advanced alcoholic liver disease. Gut 43:262–266PubMed Grove J, Daly AK, Burt AD, Guzail M, James OF, Bassendine MF et al (1998) Heterozygotes for HFE mutations have no increased risk of advanced alcoholic liver disease. Gut 43:262–266PubMed
28.
go back to reference Roberts AG, Whatley SD, Morgan RR, Worwood M, Elder GH (1997) Increased frequency of the haemochromatosis Cys282Tyr mutation in sporadic porphyria cutanea tarda. Lancet 349:321–323PubMed Roberts AG, Whatley SD, Morgan RR, Worwood M, Elder GH (1997) Increased frequency of the haemochromatosis Cys282Tyr mutation in sporadic porphyria cutanea tarda. Lancet 349:321–323PubMed
29.
go back to reference Willis G, Jennings BA, Goodman E, Fellows IW, Wimperis JZ (1997) A high prevalence of HLA-H 845A mutations in hemochromatosis patients and the normal population in eastern England. Blood Cells Mol Dis 23:288–291PubMed Willis G, Jennings BA, Goodman E, Fellows IW, Wimperis JZ (1997) A high prevalence of HLA-H 845A mutations in hemochromatosis patients and the normal population in eastern England. Blood Cells Mol Dis 23:288–291PubMed
30.
go back to reference Jackson HA, Carter K, Darke C, Guttridge MG, Ravine D, Hutton RD et al (2001) HFE mutations, iron deficiency and overload in 10,500 blood donors. Br J Haematol 114:474–484PubMed Jackson HA, Carter K, Darke C, Guttridge MG, Ravine D, Hutton RD et al (2001) HFE mutations, iron deficiency and overload in 10,500 blood donors. Br J Haematol 114:474–484PubMed
31.
go back to reference Merryweather-Clarke AT, Worwood M, Parkinson L, Mattock C, Pointon JJ, Shearman JD et al (1998) The effect of HFE mutations on serum ferritin and transferrin saturation in the Jersey population. Br J Haematol 101:369–373PubMed Merryweather-Clarke AT, Worwood M, Parkinson L, Mattock C, Pointon JJ, Shearman JD et al (1998) The effect of HFE mutations on serum ferritin and transferrin saturation in the Jersey population. Br J Haematol 101:369–373PubMed
Metadata
Title
Frequency of the C282Y and H63D mutations of the hemochromatosis gene (HFE) in 2501 ethnic Danes
Authors
Nils Milman
Palle Pedersen
Lars Ovesen
Gitte V. Melsen
Kirsten Fenger
Publication date
01-10-2004
Publisher
Springer-Verlag
Published in
Annals of Hematology / Issue 10/2004
Print ISSN: 0939-5555
Electronic ISSN: 1432-0584
DOI
https://doi.org/10.1007/s00277-004-0874-7

Other articles of this Issue 10/2004

Annals of Hematology 10/2004 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine